News >

Prostate Cancer Screening and Surveillance Continue to Evolve

Gina Columbus @ginacolumbusonc
Published: Thursday, Mar 29, 2018

William K. Kelly, DO

William K. Kelly, DO
Developments in screening and localized treatment for prostate cancer are two components that have been part of the prostate cancer field’s transformation, explains William K. Kelly, DO, adding that treatment of these patients must involve a multidisciplinary approach. “Prostate cancer is not 1 disease; it is [made up of] multiple diseases and it takes multiple people to treat a patient,” Kelly said.

on Prostate Cancer, Kelly, professor, director, Division of Solid Tumor Oncology, Thomas Jefferson University Hospital, discussed the evolving imaging techniques and emerging therapeutic approaches in prostate cancer.

OncLive: What are some notable advancements in prostate cancer?

Kelly: It starts off with localized disease; we are really starting to rethink what we can do with [that setting]. In the meeting, Dr Edouard Trabulsi introduced the fact that, even in patients with locally advanced disease, there is a role for local control of tumor. We forgot that before because, in all of the other tumor types, we have maximized local control of the tumor.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 2nd Annual International Congress on Oncology Pathology™Aug 31, 20191.5
Publication Bottom Border
Border Publication
x